Inspire Medical Systems

Company INSP

Last mentioned: Mar 20, 2026

Stories mentioning Inspire Medical Systems 2

pharma Neutral

Nyxoah and Alumis Miss Q4 Earnings Estimates Amid Scaling R&D Costs

Medical technology firm Nyxoah and immunology specialist Alumis both reported quarterly earnings that fell short of analyst expectations by $0.04 per share. The misses reflect the high capital intensity of late-stage clinical development and the commercial infrastructure build-out required for upcoming product launches.

2 sources
medical-devices Neutral

Nyxoah and Alumis Report Q4 Earnings Misses Amid Clinical Scaling Pressures

Both Nyxoah and Alumis reported quarterly earnings that missed analyst expectations by $0.04 per share, reflecting the high operational costs of late-stage clinical trials and pre-commercialization activities. Despite the financial shortfall, both companies remain on track with pivotal regulatory and clinical milestones in the sleep apnea and immunology sectors.

2 sources